Biocon Biologics

Hopefully, this case will initiate as deep a clean up and introspection as the 2012 PCC report

A statement from the company claimed that besides its employees, all its consultants, suppliers and partners are also bound by a…

Abevmy, co-developed by the two companies, is a biosimilar to Roche’s Avastin (Bevacizumab), and has been approved by Health…

Once the deal is complete, Serum Institute Life Sciences will have about 15 per cent stake in Biocon Biologics, according to the…

FY22 revenue at Rs 8,397 crores, up 14 per cent; core EBITDA up 18 per cent at Rs 2,669 crores; PBT (before Exceptional Item) at…

Biocon Biologics’ Insugen formulations will be available to patients at all Ministry of Health hospitals, district health offices…

Celerity Pharma uses Biocon Biologics’ insulin drug substance to develop the product

Shaw is among the 80 luminaries to be appointed to the RSE’s Fellowship this year

Viatris to provide commercial and other transition services for an expected period of two years to ensure continuity of customer…

Biosimilars up by 28 per cent at Rs 981 crores; research services up by 10 per cent at Rs 641 crores and generics up by seven per…